Table 2.
Adverse events reported in > 1 patient charts
| All patients (N = 65) | ||
|---|---|---|
| n (%) | Events | |
| Patients with ≥ 1 AEsa | 33 (50.8) | 70 |
| Specific AEs | ||
| Blurred vision | 10 (15.4) | 12 |
| Dryness | 8 (12.3) | 11 |
| Irritation | 5 (7.7) | 6 |
| Itching | 5 (7.7) | 6 |
| Light sensitivity | 5 (7.7) | 5 |
| Burning | 4 (6.2) | 4 |
| Eye pain | 3 (4.6) | 4 |
| Tearing | 3 (4.6) | 3 |
| Change in vision | 2 (3.1) | 2 |
| Keratitis | 2 (3.1) | 3 |
| Macular degeneration | 2 (3.1) | 3 |
AE reports are limited to those recorded in the charts
AE adverse event
aAE reports in eyes not treated with LBN were not counted